Paragonix Technologies Announces GUARDIAN-LUNG, The First Global Registry For Studying Donor Lung Preservation
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announces the launch of its clinical global registry, GUARDIAN-LUNG (Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs). The GUARDIAN-LUNG study is…